Salicylhydroxamic acid

From WikiMD's WELLNESSPEDIA

Salicylhydroxamic acid (SHA) is a hydroxamic acid derivative of salicylic acid. It is a chelating agent and an inhibitor of bacterial and plant urease and also used in the treatment of urinary tract infections.

Chemistry[edit]

Salicylhydroxamic acid is a type of hydroxamic acid, which are organic compounds bearing a hydroxyl group and an amino group on adjacent carbon atoms. It is derived from salicylic acid, a type of phenolic acid known for its use in skincare and medicine.

Pharmacology[edit]

Salicylhydroxamic acid has been used as a chelating agent, a type of substance that can form several bonds to a single metal ion. In medicine, it is used as an inhibitor of bacterial and plant urease, an enzyme that catalyzes the hydrolysis of urea. This makes it useful in the treatment of urinary tract infections (UTIs), as it can prevent the formation of kidney stones and other complications associated with high urease activity.

Medical Uses[edit]

Salicylhydroxamic acid is primarily used in the treatment of urinary tract infections. It works by inhibiting the activity of urease, an enzyme that is often produced by bacteria in the urinary tract. By inhibiting this enzyme, it can help to prevent the formation of kidney stones and other complications associated with UTIs.

Safety[edit]

As with any medication, there are potential side effects associated with the use of salicylhydroxamic acid. These can include gastrointestinal issues, such as nausea and vomiting, as well as skin reactions. It is important to consult with a healthcare provider before starting any new medication.

See Also[edit]

This article is a stub related to chemistry. You can help WikiMD by expanding it!


Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.


Salicylhydroxamic_acid[edit]

  • Salicylhydroxamic acid
    Salicylhydroxamic acid

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Salicylhydroxamic_acid&oldid=6347588"